232 related articles for article (PubMed ID: 22792389)
21. von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene.
Sadler B; Christopherson PA; Haller G; Montgomery RR; Di Paola J
Blood; 2021 Jun; 137(23):3277-3283. PubMed ID: 33556167
[TBL] [Abstract][Full Text] [Related]
22. The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease.
Seaman CD; Ragni MV
Clin Appl Thromb Hemost; 2018 Apr; 24(3):434-438. PubMed ID: 28874064
[TBL] [Abstract][Full Text] [Related]
23. Interaction networks of Weibel-Palade body regulators syntaxin-3 and syntaxin binding protein 5 in endothelial cells.
Schillemans M; Karampini E; Hoogendijk AJ; Wahedi M; van Alphen FPJ; van den Biggelaar M; Voorberg J; Bierings R
J Proteomics; 2019 Aug; 205():103417. PubMed ID: 31201948
[TBL] [Abstract][Full Text] [Related]
24. Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.
de Jong A; Dirven RJ; Oud JA; Tio D; van Vlijmen BJM; Eikenboom J
J Thromb Haemost; 2018 Jul; 16(7):1357-1368. PubMed ID: 29734512
[TBL] [Abstract][Full Text] [Related]
25. Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM; Atiq F; Blijlevens NMA; Brons PPT; Krouwel S; Laros-van Gorkom BAP; Leebeek FWG; Nieuwenhuizen L; Schoormans SCM; Simons A; Meijer D; van Heerde WL; Schols SEM
J Thromb Haemost; 2022 Feb; 20(2):316-327. PubMed ID: 34758185
[TBL] [Abstract][Full Text] [Related]
26. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
27. No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Flood VH; Friedman KD; Gill JC; Haberichter SL; Christopherson PA; Branchford BR; Hoffmann RG; Abshire TC; Dunn AL; Di Paola JA; Hoots WK; Brown DL; Leissinger C; Lusher JM; Ragni MV; Shapiro AD; Montgomery RR
Blood; 2013 May; 121(18):3742-4. PubMed ID: 23520336
[TBL] [Abstract][Full Text] [Related]
28. von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.
Atiq F; Schütte LM; Looijen AEM; Boender J; Cnossen MH; Eikenboom J; de Maat MPM; Kruip MJHA; Leebeek FWG
Blood Adv; 2019 Dec; 3(24):4147-4154. PubMed ID: 31834934
[TBL] [Abstract][Full Text] [Related]
29. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.
Starke RD; Paschalaki KE; Dyer CE; Harrison-Lavoie KJ; Cutler JA; McKinnon TA; Millar CM; Cutler DF; Laffan MA; Randi AM
Blood; 2013 Apr; 121(14):2773-84. PubMed ID: 23355534
[TBL] [Abstract][Full Text] [Related]
31. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
32. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
[TBL] [Abstract][Full Text] [Related]
33. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
34. Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
Nogami K; Ogiwara K; Yada K; Shida Y; Takeyama M; Yaoi H; Minami H; Furukawa S; Hosokawa K; Shima M
J Thromb Haemost; 2016 Apr; 14(4):667-74. PubMed ID: 27061057
[TBL] [Abstract][Full Text] [Related]
35. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.
Atiq F; Blok R; van Kwawegen CB; Doherty D; Lavin M; van der Bom JG; O'Connell NM; de Meris J; Ryan K; Schols SEM; Byrne M; Heubel-Moenen FCJI; van Galen KPM; Preston RJS; Cnossen MH; Fijnvandraat K; Baker RI; Meijer K; James P; Di Paola J; Eikenboom J; Leebeek FWG; O'Donnell JS
Blood; 2024 Apr; 143(14):1414-1424. PubMed ID: 38142407
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
Christopherson PA; Haberichter SL; Flood VH; Perry CL; Sadler BE; Bellissimo DB; Di Paola J; Montgomery RR;
J Thromb Haemost; 2022 Jul; 20(7):1576-1588. PubMed ID: 35343054
[TBL] [Abstract][Full Text] [Related]
37. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
Kalot MA; Husainat N; El Alayli A; Abughanimeh O; Diab O; Tayiem S; Madoukh B; Dimassi AB; Qureini A; Ameer B; Eikenboom JCJ; Giraud N; McLintock C; McRae S; Montgomery RR; O'Donnell JS; Scappe N; Sidonio RF; Brignardello-Petersen R; Flood VH; Connell NT; James PD; Mustafa RA
Blood Adv; 2022 Jan; 6(1):62-71. PubMed ID: 34610118
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
Huang J; Huffman JE; Yamakuchi M; Trompet S; Asselbergs FW; Sabater-Lleal M; Trégouët DA; Chen WM; Smith NL; Kleber ME; Shin SY; Becker DM; Tang W; Dehghan A; Johnson AD; Truong V; Folkersen L; Yang Q; Oudot-Mellkah T; Buckley BM; Moore JH; Williams FM; Campbell H; Silbernagel G; Vitart V; Rudan I; Tofler GH; Navis GJ; Destefano A; Wright AF; Chen MH; de Craen AJ; Worrall BB; Rudnicka AR; Rumley A; Bookman EB; Psaty BM; Chen F; Keene KL; Franco OH; Böhm BO; Uitterlinden AG; Carter AM; Jukema JW; Sattar N; Bis JC; Ikram MA; ; Sale MM; McKnight B; Fornage M; Ford I; Taylor K; Slagboom PE; McArdle WL; Hsu FC; Franco-Cereceda A; Goodall AH; Yanek LR; Furie KL; Cushman M; Hofman A; Witteman JC; Folsom AR; Basu S; Matijevic N; van Gilst WH; Wilson JF; Westendorp RG; Kathiresan S; Reilly MP; ; Tracy RP; Polasek O; Winkelmann BR; Grant PJ; Hillege HL; Cambien F; Stott DJ; Lowe GD; Spector TD; Meigs JB; Marz W; Eriksson P; Becker LC; Morange PE; Soranzo N; Williams SM; Hayward C; van der Harst P; Hamsten A; Lowenstein CJ; Strachan DP; O'Donnell CJ;
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1093-101. PubMed ID: 24578379
[TBL] [Abstract][Full Text] [Related]
39. Controversies in the diagnosis of Type 1 von Willebrand disease.
Bowman ML; James PD
Int J Lab Hematol; 2017 May; 39 Suppl 1():61-68. PubMed ID: 28447419
[TBL] [Abstract][Full Text] [Related]
40. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
